Health Care·Health Care Equipment·$12.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.00 | N/A | -100.00% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.00 | N/A | -100.00% |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management's commentary was cautious, highlighting ongoing challenges without providing specific guidance. They remain focused on future growth.
Management did not provide specific revenue figures or guidance for the quarter.
The company acknowledged challenges but expressed commitment to long-term growth.
Penumbra Inc reported an EPS of $0.00, missing expectations, but the stock still rose by 4.41%. This increase may reflect investor optimism about the company's long-term potential despite the lack of specific revenue figures or guidance. The market appears to be looking beyond the immediate results.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SEMPRA
May 4, 2020